Melissa Lozner

Senior Vice President, Chief Compliance Officer · Regeneron Pharmaceuticals

Biopharmaceuticals

Melissa Lozner is senior vice president and chief compliance officer of Regeneron Pharmaceuticals. She joined in 2022 and oversees the global corporate compliance program, following legal and compliance leadership at Rafael Holdings and Novartis Oncology.

Last reviewed: Oct 21, 2026

Melissa Lozner

Senior Vice President, Chief Compliance Officer Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Melissa Lozner is senior vice president and chief compliance officer of Regeneron Pharmaceuticals. She joined in 2022 and oversees the global corporate compliance program, following legal and compliance leadership at Rafael Holdings and Novartis Oncology.

Career Highlights

  • Joined Regeneron in 2022.
  • Established a compliance risk navigation and advisory services group.
  • Previously served as chief compliance officer and special counsel at Rafael Holdings.

Professional Journey

Lozner began her legal career outside the pharmaceutical industry, working as a litigation attorney and as a law clerk to Boyce F. Martin Jr. of the U.S. Court of Appeals for the Sixth Circuit. She subsequently held several positions at Novartis Oncology, including senior legal counsel, head of U.S. Ethics, Risk and Compliance, and interim head of Global Integrity and Compliance.

At Rafael Holdings, she served as chief compliance officer and special counsel and built a compliance program for a start-up biotechnology company. She joined Regeneron in 2022 to lead its corporate compliance program.

Her work at Regeneron has included adapting the program and organizational structure to international expansion. She also created a compliance risk navigation and advisory services group, intended to integrate compliance advice across the business. The role builds on her experience establishing programs and advising pharmaceutical organizations in different stages of development.

Education

Lozner earned a BS from Cornell University and a JD from Boston University School of Law.